Our top pick for
Bridgewater Bancshares, Inc is a banks-regional business based in the US. Bridgewater Bancshares shares (BWB) are listed on the NASDAQ and all prices are listed in US Dollars. Bridgewater Bancshares employs 183 staff and has a trailing 12-month revenue of around USD$80.3 million.
|52-week range||USD$7.99 - USD$15.975|
|50-day moving average||USD$14.0312|
|200-day moving average||USD$11.7631|
|Wall St. target price||USD$16|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.93|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Bridgewater Bancshares stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bridgewater Bancshares's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bridgewater Bancshares's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Bridgewater Bancshares shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||USD$80.3 million|
|Operating margin TTM||44.41%|
|Gross profit TTM||USD$80.3 million|
|Return on assets TTM||1.05%|
|Return on equity TTM||10.66%|
|Market capitalisation||USD$447.2 million|
TTM: trailing 12 months
There are currently 257,002 Bridgewater Bancshares shares held short by investors – that's known as Bridgewater Bancshares's "short interest". This figure is 1% up from 254,415 last month.
There are a few different ways that this level of interest in shorting Bridgewater Bancshares shares can be evaluated.
Bridgewater Bancshares's "short interest ratio" (SIR) is the quantity of Bridgewater Bancshares shares currently shorted divided by the average quantity of Bridgewater Bancshares shares traded daily (recently around 71588.300835655). Bridgewater Bancshares's SIR currently stands at 3.59. In other words for every 100,000 Bridgewater Bancshares shares traded daily on the market, roughly 3590 shares are currently held short.
However Bridgewater Bancshares's short interest can also be evaluated against the total number of Bridgewater Bancshares shares, or, against the total number of tradable Bridgewater Bancshares shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bridgewater Bancshares's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Bridgewater Bancshares shares in existence, roughly 10 shares are currently held short) or 0.011% of the tradable shares (for every 100,000 tradable Bridgewater Bancshares shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Bridgewater Bancshares.
Find out more about how you can short Bridgewater Bancshares stock.
We're not expecting Bridgewater Bancshares to pay a dividend over the next 12 months.
Over the last 12 months, Bridgewater Bancshares's shares have ranged in value from as little as $7.99 up to $15.975. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bridgewater Bancshares's is 0.7834. This would suggest that Bridgewater Bancshares's shares are less volatile than average (for this exchange).
Bridgewater Bancshares, Inc. operates as the bank holding company for Bridgewater Bank that provides banking products and services to commercial real estate investors, small business entrepreneurs, and high-net-worth individuals in the United States. It offers demand, savings and money market, time, interest and noninterest bearing transaction, and brokered deposits, as well as certificates of deposit. The company also provides commercial loans to sole proprietorships, partnerships, corporations, and other business enterprises to finance accounts receivable or inventory, capital assets, or other business related purposes; construction and land development loans; 1-4 family mortgage loans; multifamily lending products; owner and non-owner occupied commercial real estate loans; and consumer and other loans. It has seven full-service offices located in Bloomington, Greenwood, Minneapolis, St. Louis Park, Orono, and St. Paul, Minnesota. The company was founded in 2005 and is headquartered in Saint Louis Park, Minnesota.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.